CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Mazujind JoJojinn
Country: Estonia
Language: English (Spanish)
Genre: Life
Published (Last): 27 September 2004
Pages: 388
PDF File Size: 7.65 Mb
ePub File Size: 15.32 Mb
ISBN: 699-6-70550-262-9
Downloads: 98293
Price: Free* [*Free Regsitration Required]
Uploader: Mikanos

CAT gastro-entérologie

Comparison of efficacy icterw search for predictive factors guiding treatment choice. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

New insights and treatment implications.

Copy of CAT devant une péritonite by Ismail Chafik on Prezi

Dig Liver Dis ; J Interferon Cytokine Res ; Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: Fazio N, Milione M. WHO classification of tumours of the digestive system. TNM staging of midgut and hindgut neuro endocrine tumors: Bilan initial et surveillance: Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.


Updating the management of patients with rectal neuroendocrine tumors. MGMT expression ub response to temozolomide in pancreatic neuroendocrine tumors.

The Concept of Skip Metastases. Prognostic factors influencing survival from metastatic stage IV gastroenteropancreatic well-differentiated endocrine carcinoma. O6-Methylguanine-DNA methyltransferase status in neuroendocrine act Intervention in gastro-enteropancreatic neuroendocrine tumours. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome RADIANT Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

WHO classification of tumours of endocrine organs. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

Hepatic ddvant embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: TNM staging of foregut neuro endocrine tumors: J 15 et J 30 puis tous les mois Clinique: Chimioembolisation [Zappa ] Contre-indications: Ki index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas.

TNM Classification of malignant tumours. TNE de primitif inconnu.

La classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.


Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: Best Pract Res Clin Gastroenterol. Expert Rev Anticancer Ther. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: Pour en savoir plus: Examens morphologiques initiaux Cadiot G, Mignon M. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: N Engl J Med.

Combined liver cst and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Int J Biol Markers.